Profiling the Lipidome of Adrenal Cancer Tissues Using Fast LC-MS Methodologies

Significance of the Topic

Adrenocortical carcinoma (ACC) is a rare malignancy with limited treatment options and poor long-term survival. Alterations in lipid metabolism have emerged as key features in many cancers, offering potential biomarkers and therapeutic targets. A rapid and comprehensive lipid profiling approach can therefore provide critical insights into ACC biology and inform novel intervention strategies.

Study Objectives and Overview

This study aimed to compare the lipid composition of ACC tissues with benign adrenal nodules using a fast liquid chromatography–mass spectrometry (LC-MS) workflow. By integrating high-resolution MS data acquisition with advanced informatics, the research sought to identify dysregulated lipid species and associated metabolic pathways underpinning ACC development.

Methodology and Instrumentation

Sample Preparation and Extraction:

• Adrenal tissue specimens (ACC and benign) collected and flash-frozen.
• Lipid extraction following established protocols (Nature Protocols method).

Chromatography and Mass Spectrometry:

• Fast chromatographic separation coupled to a high-resolution Xevo™ MRT MS system operated in MSE (data-independent acquisition) mode.
• Acquisition in both positive and negative electrospray ionization (ESI+/–) with sub-1 ppm mass accuracy.

Data Processing and Analysis:

• Conversion to mzML format and processing via LipoStar for peak picking, normalization, and annotation.
• Multivariate statistical analysis including principal component analysis (PCA), variable importance in projection (VIP), and hierarchical clustering.
• Pathway mapping using LipidMaps and an in-house database.

Key Results and Discussion

PCA revealed clear discrimination between ACC and benign groups, with tight clustering of pooled quality controls. Glycerophospholipids and glycerolipids dominated the lipidome, while specific ceramides (e.g., Cer d42:1) and free fatty acids (e.g., FA 18:0) exhibited significant down-regulation in ACC samples. Pathway analysis highlighted choline metabolism, fatty acid biosynthesis, and glycerophospholipid metabolism as highly perturbed, reflecting altered membrane dynamics and signaling in cancer progression.

Benefits and Practical Applications

• Provides a robust, high-throughput platform for lipid biomarker discovery in ACC.
• Delivers confident lipid identifications (sub-ppm accuracy) suitable for translational research.
• Offers a streamlined workflow adaptable to QA/QC and clinical proteomics laboratories.

Future Trends and Potential Applications

• Integration with multi-omics data (proteomics, genomics) to build comprehensive ACC molecular profiles.
• Development of targeted lipid assays for diagnostic and prognostic use.
• Real-time clinical monitoring of lipid alterations during therapy.
• Exploration of lipid metabolic enzymes as therapeutic targets.

Conclusion

The application of a fast LC-MS workflow combined with advanced informatics enabled detailed profiling of the adrenal lipidome, uncovering key dysregulated lipids and pathways in ACC. This pipeline offers a valuable tool for biomarker discovery and sheds light on metabolic vulnerabilities that may guide future therapeutic strategies.

References

1. European Society for Paediatric Oncology. Adrenal Tumors in Children and Adolescents.
2. University of Michigan Rogel Cancer Center. Adrenal Cancer Survival Rates.
3. National Cancer Institute. Adrenocortical Cancer Treatment (PDQ).
4. American Cancer Society. Treatments for Adrenal Cancer.
5. Glunde K, et al. Choline metabolism in malignant transformation. Nature Rev Cancer. 11:835–848 (2011).
6. Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 122:4–22 (2020).
7. Chen N, et al. PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer. J Transl Med. 22:249 (2024).